DH
Diversified Healthcare Trust, 5.625% Senior Notes due 2042
DHCNI · NASDAQ
$18.20 +1.17% (+$0.21)
1M -2.36%
Market Cap $901.7M
P/E Ratio -
Div. Yield 7.79%
ROE 16.22%
Bulios Fair Price
$14.42
20.8% downside
Current Price
$18.2
Undervalued Fair Value Overvalued
According to Bulios Fair Price, DHCNI is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.60x
P/B 0.57x
P/E N/A
Growth
50 /100
Stable Rev. growth 6.21%
Book val. growth 14.22%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 5.25%
Net margin 17.73%
FCF margin 6.44%
Quality
15 /100
Poor ROIC 0.74%
ROE 16.22%
Asset turnover 0.35x
Debt
49 /100
Moderate Debt/Equity 1.53x
Current ratio 188.99x
Debt/Assets 0.57x
Stability
45 /100
Moderate Beta 1.14x
Rev. volatility 3.52%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DHCNI
Online
Sector
Real Estate
Industry
REIT - Healthcare Facilities
CEO
Christopher J. Bilotto
Employees
600
Headquarters
Newton